Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden

• Asıl Yazarlar: E. Kågström (Yazar), A. Lannergård (Yazar), J. El Khosht (Yazar), P. Lörelius (Yazar), J. Månflod (Yazar), S. Strömdahl (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2023-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background The World Health Organization has set a goal to reach world elimination of hepatitis C virus (HCV) by 2030. Needle and syringe programs (NSP) for people who inject drugs (PWID) are crucial to achieve this goal. The NSP in Uppsala, Sweden, was opened in 2016 and has since 2018 pro...